March 15, 2021
Article
A comparative study of same-day and seven-day TB test results show there is little difference in HIV treatment adherence or outcomes at 48 weeks.
Phase 1/2 trial results showed the immunomodulary vaccine regimen could induce significant T-cell response in patients with HIV.
March 14, 2021
Video
A bamlanivimab study showed a 72% reduction in the incidence of COVID-19 and an 80% reduction of progression in the virus in residents in assisted living facilities and nursing staff.
March 11, 2021
Managing mental health in adults living with HIV is paramount during the COVID-19 pandemic.
March 10, 2021
While at the earliest stages of potential development, long-acting/extended release (LA/ER) formulations for treatment and prevention of TB could be something to be studied in the future.
Index testing declined in countries including Malawi, Lesotho and Zimbabwe.
Deep learning models identified the largest differences in resting state network topology occurred.
Plasma proteome confirmed the association between cellular and humoral SARS-CoV-2 immunity.
The prognostic proteins identified can serve as the basis of future pathway and network analyses.
Dapivrine (DPV) was studied in 1-month and 3-month durations.
